Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies
- PMID: 22550610
- PMCID: PMC3324936
- DOI: 10.1155/2012/271732
Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies
Abstract
Neuroinflammation in Parkinson's disease (PD) is a chronic process that is associated with alteration of glial cells, including astrocytes and microglia. However, the precise mechanisms remain obscure. To better understand neuroinflammation in PD, we focused on glial activation in α-synuclein (αS) transgenic and related model mice. In the majority of αS transgenic mice, astrogliosis was observed concomitantly with accumulation of αS during the early stage of neurodegeneration. However, microglia were not extensively activated unless the mice were treated with lipopolysaccharides or through further genetic modification of other molecules, including familial PD risk factors. Thus, the results in αS transgenic mice and related model mice are consistent with the idea that neuroinflammation in PD is a double-edged sword that is protective in the early stage of neurodegeneration but becomes detrimental with disease progression.
Figures
Similar articles
-
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.Environ Health Perspect. 2011 Jun;119(6):807-14. doi: 10.1289/ehp.1003013. Epub 2011 Jan 18. Environ Health Perspect. 2011. PMID: 21245015 Free PMC article.
-
Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions.Acta Neuropathol Commun. 2020 Aug 12;8(1):133. doi: 10.1186/s40478-020-00993-8. Acta Neuropathol Commun. 2020. PMID: 32787922 Free PMC article.
-
Disease-Modifying Effect of Adiponectin in Model of α-Synucleinopathies.Ann Clin Transl Neurol. 2014 Jul 3;1(7):479-489. doi: 10.1002/acn3.77. Ann Clin Transl Neurol. 2014. PMID: 25126588 Free PMC article.
-
Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.Cent Nerv Syst Agents Med Chem. 2015;15(2):109-16. doi: 10.2174/1871524915666150421114338. Cent Nerv Syst Agents Med Chem. 2015. PMID: 25896035 Review.
-
Neuroinflammation in Parkinson's disease and its potential as therapeutic target.Transl Neurodegener. 2015 Oct 12;4:19. doi: 10.1186/s40035-015-0042-0. eCollection 2015. Transl Neurodegener. 2015. PMID: 26464797 Free PMC article. Review.
Cited by
-
Gut and brain profiles that resemble pre-motor and early-stage Parkinson's disease in methamphetamine self-administering rats.Drug Alcohol Depend. 2021 Aug 1;225:108746. doi: 10.1016/j.drugalcdep.2021.108746. Epub 2021 May 20. Drug Alcohol Depend. 2021. PMID: 34098381 Free PMC article.
-
Visualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based Probes.PLoS One. 2015 Sep 29;10(9):e0138107. doi: 10.1371/journal.pone.0138107. eCollection 2015. PLoS One. 2015. PMID: 26418157 Free PMC article.
-
Combination therapies: The next logical Step for the treatment of synucleinopathies?Mov Disord. 2016 Feb;31(2):225-34. doi: 10.1002/mds.26428. Epub 2015 Sep 21. Mov Disord. 2016. PMID: 26388203 Free PMC article. Review.
-
p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease.Int J Mol Cell Med. 2015 Spring;4(2):67-86. Int J Mol Cell Med. 2015. PMID: 26261796 Free PMC article. Review.
-
Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson's Disease Model in Rats.Parkinsons Dis. 2014;2014:519615. doi: 10.1155/2014/519615. Epub 2014 Jun 25. Parkinsons Dis. 2014. PMID: 25061534 Free PMC article.
References
-
- Trojanowski JQ, Goedert M, Iwatsubo T, Lee VMY. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson’s disease and Lewy body dementia. Cell Death and Differentiation. 1998;5(10):832–837. - PubMed
-
- Rochet JC, Lansbury PT., Jr. Amyloid fibrillogenesis: themes and variations. Current Opinion in Structural Biology. 2000;10(1):60–68. - PubMed
-
- Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience. 2007;8(1):57–69. - PubMed
LinkOut - more resources
Full Text Sources